Ameba Ownd

アプリで簡単、無料ホームページ作成

Who owns genesis healthcare

2022.01.13 00:01




















Our Services. MarketScreener Portfolios. Add to my list. Genesis Healthcare, Inc. It operates through three segments: inpatient services, rehabilitation therapy services and other services.


Of the facilities, are leased, ten are owned, 12 are managed and 73 are joint ventures. Rehabilitation therapy services includes speech-language pathology, physical therapy, occupational therapy and respiratory therapy, to approximately 1, healthcare locations in 42 states, the District of Columbia and China, including facilities operated by its.


It provides an array of other specialty medical services, including physician services, staffing services, and other healthcare related services. In partnership with Allbrands. KGAA Connections : Genesis Healthcare, Inc.


Harrington Richard A. Feifer Joseph C. Montgomery Paul D. Bach James W. Tabak James H. Bloem Robert H. Fish Arnold M. All rights reserved. Show password. Business Summary. Number of employees : 47 people. Sales per Business. Sales per region. Harry James Wilson. Thomas DiVittorio. Richard A. Feifer, Dr. Joseph C. Stephen S. Michael S. JoAnne Reifsnyder, Dr.


Members of the board. David S. Arnold M. Robert Hartman. John F. Issac M. Steven D. The move also marks a significant turn in the history of Genesis, which was founded in , and has cycled through public and private ownership over the last 20 years, each stage piling on debt.


Advocates for the elderly and unions that represent nursing home workers have decried the impact of private equity ownership on the nursing-home sector.


In the deal, ReGen received two seats on the Genesis board. Harrington is cofounder and managing partner of Pinta Capital Partners, a New York private equity firm that specializes in nursing homes and other health-care sectors.


The other seat went to John Randazzo, who is a senior advisor to private equity giant Warburg Pincus and executive chairman of a large dermatology company in Florida that is backed by Griffin Partners, a private-equity firm in San Francisco.


The arrangement with ReGen also requires Genesis to stop listing its shares on the New York Stock Exchange, where they have traded without success since early The shares are expected to continue trading over-the-counter in the OTC Pink Open Market, but the company will no longer provide financial reports to the U.


Securities and Exchange Commission after filing a final annual report by March That amounts to more than a third of Genesis locations in those two states, where Genesis employs 9,